Nab-paclitaxel,Cyclophosphamide
immunitybio
[]
$ibrx immunitybio announces presentation at asco gi 2023 of fully enrolled trial in third-line and greater pancreatic cancer and update on fda type b meetings regarding paths to registration 1/3
¬ Retweeting Bloomberg's Feed all in one place.

¬ Market & Stock Updates

¬ I'm Barry Bloomberg putting out the fastest updates!

¬ Making your life easier.